Discovering multifaceted role of vanillic acid beyond flavours: Nutraceutical and therapeutic potential

Background: Vanillic acid is a phenolic compound, found in various dietary sources and medicinal plants. Apart from its extraction from these biological sources, it is also synthesized chemically. It is used as flavouring agent in various food products. It possesses anticancer, antiobesity, antidiabetic, antibacterial, anti-inflammatory, and antioxidant effects. Despite possessing good therapeutic potential and safety profile, it has not been well explored as nutraceutical or, therapeutic moiety.Scope and approach: Literature search was conducted to systematically review the various mechanistic pathways through which vanillic acid showed multiple therapeutic effects. Along with these pathways, other applications of vanillic acid and its derivatives are highlighted. Some of the patents that have been filed hitherto, for the production and uses of vanillic acid are also entailed in the manuscript.Key findings and conclusion: Vanillic acid exerts diverse bioactivity against cancer, diabetes, obesity, neurodegenerative, cardiovascular, and hepatic diseases by inhibition of the associated molecular pathways. Its derivatives also possess the therapeutic potential to treat autoimmune diseases as well as fungal and bacterial infections. Owing to these benefits, vanillic acid has great potential to be used as a nutraceutical and provides scope for therapeutic uses beyond its traditional use as a flavouring agent. However, its oral bioavailability is limited due to its rapid elimination (metabolism) from the plasma. This, in turn, impedes its successful delivery through conventional formulations. Hence, efforts are required to develop nanoformulations of vanillic acid to overcome the associated challenges.

Automated summary

Vanillic acid exhibits diverse therapeutic effects against cancer, diabetes, obesity, neurodegenerative, cardiovascular, and hepatic diseases. Its derivatives also show potential in treating autoimmune diseases and fungal/bacterial infections. However, its limited oral bioavailability due to rapid metabolism hampers its delivery via conventional formulations. Efforts are required to develop nanoformulations of vanillic acid to overcome these challenges.